Orion Nutraceuticals (CSE: ORI) Combines the Potential of High Quality CBD Products with Superior Growing Operations

The rapidly-growing legal cannabis industry has triggered a number of high-upside opportunities for investors.

In fact, according to experts’ projections, the global legal marijuana market is expected to reach $146.4 billion by the end of 2025.[i]

As this market continues to grow and mature, investors looking for the next wave of legal cannabis profits should consider looking beyond licensed producers…and toward the next emerging trend in the cannabis space.

One forward-thinking company – Orion Nutraceuticals (CSE: ORI) – is working to become a global leader in the next emerging trend…and capitalizing on a high-upside opportunity in Latin America at the same time.

Thanks to a potentially lucrative strategic partnership that allows for sustainable growth in Colombia – quite possibly the best place on earth to grow cannabis – Orion Nutraceuticals could now be among the most attractive cannabis investments to own.

Orion Nutraceuticals (CSE: ORI) is Well-Positioned to Pounce on Emerging Trends in Both the Cannabis and Nutraceutical Sectors

One trend that offers strong upside potential is the cannabidiol (CBD) market, which is projected to grow as much as 700% by 2020.[iii]

In fact, one report by a prominent industry research publication calls for the CBD market to reach annual revenues of $2.1 billion by 2020 – an increase of more than 700% in just four years.[iv]

Orion is executing a comprehensive plan to become a global leader in the production of medical and recreational cannabinoid extracts and oils, nutraceuticals and pharmaceuticals.

Orion is rapidly establishing first mover advantage in this space by helping open door to a new range of CBD-based and CBD-infused products which offer potentially better solutions in a wide range of products, including:

Orion Nutraceuticals (CSE: ORI) is working to use cannabis extracts and oils as the foundation to develop an innovative line of branded nutraceutical and pharmaceutical products…as well as selling bulk oils to meet global industry demand.

Orion is well-positioned to capitalize on powerful emerging trends in both the international cannabis and nutraceutical sectors and to become a world-class brand differentiated by the quality, variety, price point, and marketing of its products.

But it’s the company’s unique partnership on the production side that offers a significant advantage.

Colombia: The Best Place on Earth for Scalable Cannabis Growth

Orion Nutraceuticals’ (CSE: ORI) plans for developing large-scale production capacity call for a distribution hub headquartered in Canada which will provide high-quality CBD products to customers and partners throughout North America and the rest of the world.

On the production side, however, Orion has a significant competitive advantage in this space thanks to its strategic JV partnership with FCM Global – a fully-licensed Colombian cannabis producer and exporter.

With an equatorial climate that includes a predictable and bountiful daylight cycle – as well as one of the world’s top ranks for water availability and precipitation – Colombia offers possibly the world’s best environment for scalable cannabis growth.

FCM Global S.A.S. is a fully-licensed Colombian medical cannabis company producing a range of extracts, isolates, oils and microemulsions in support of finished goods manufacturers in legal markets worldwide.

Headquartered in Medellin, with a 235,800 sq ft production facility in La Ceja, the FCM Global platform is built and operated to GAP and GMP standards, well-organized, and integrates Orion’s complete soil-to-oil value chain.

FCM Global’s model is designed to reliably deliver lower production costs and high-quality inputs at scale to Orion’s clients in the nutritional, wellness, pharmaceutical, and cosmetic sectors.

FCM Global is currently breaking ground on FCM Tolima, a planned cultivation & production campus which covers 450 hectares and will ultimately produce 2,300 jobs and 1,000+ tons of cannabis oil per year at full capacity.

FCM Global’s facility includes enclosed naturally sunlit greenhouses with full environmental controls as well as in-house quality lab testing to ensure safety and consistency at every step.

Dried flower production costs are estimated at $0.05 per gram and extract production costs at $0.45 per gram.

Based on Orion’s 35% ownership stake – and estimating full capacity of 907 million grams – the potential exists for 260 million grams of production for Orion. Estimating a value of $5 per gram that would translate into $1.3 billion in gross sales potential for Orion Nutraceuticals (CSE: ORI) from this partnership.

Medic Oasis: Orion’s Production
Headquarters in Dorval, Quebec

Orion’s subsidiary, Medic Oasis, is a late-stage ACMPR applicant with Health Canada. Quebec is Orion’s Canadian production headquarters and the next step in building a global footprint.

Medic Oasis, when licensed, is strategic to Orion as a 99% owned subsidiary for both expanding its presence in the Canadian cannabis sector, as well as to enable import/export of oil from Colombia (via FCM) to other parts of Canada, Europe, and wider international markets.

Medic Oasis will be an instrumental part of Orion’s development efforts for certain strains, potent extracts, nutraceuticals, and pharmaceuticals which incorporate cannabis and cannabis-based medical science.

The Medic Oasis project expects to receive a Cultivation License from Health Canada in early 2019. Once approved, Orion plans to commence and complete the construction of its Quebec facility – a 30,000 square foot cannabis growing facility in Dorval, Quebec.

Orion anticipates that the Medic Oasis project will be operational by the third quarter of 2020.

Orion Nutraceuticals (CSE: ORI) is Led By an Experienced Management Team

Orion’s senior management team is among the most impressive you’ll find in the cannabis space. This seasoned group possesses…


Jonathan Fiteni – CEO, Director

Jonathan Fiteni is a cannabis pioneer who has worked over 15 years to actively bridge the divide between global investment capital and legal growers, suppliers, researchers, and medical professionals who have dedicated their lives to transforming the cannabis industry.

Mr. Fiteni has guided several industry startups, raised millions in capital for both private and public companies and developed more than 40 patent pending cannabis formulations.

Most recently Mr. Fiteni was the CEO and Director of Operations for MYM Nutraceuticals, Inc. a publicly listed (CSE) company focused on building large, licensed production facilities to serve the pharmaceutical-grade and recreational cannabis markets.

Marcelin O’Neill – CCO, Director

Marcie O’Neill brings over 24 years of experience in the management of public companies, including expertise in the areas of corporate governance and affairs, regulatory and compliance, and financial/operational oversight.

Ms. O’Neill is the Managing Director of Accrete Consulting, Inc., which delivers corporate governance and management services to public companies.

Ms. O’Neill has served as a Director for a number of firms, including Alternate Health Corp., Jagercor Energy Corp., Cervantes Capital Corp., and Mandalay Resources Corporation.

Christopher Cherry – CFO, Director

Christopher Cherry has over 15 years of corporate accounting and audit experience, having been a Chartered Accountant (CA) since February 2009 and a Certified General Accountant (CGA) since 2004.

Mr. Cherry has held a number of senior level positions, including as a Senior Accountant at KPMG and as an Auditor at Davidson and Co. LLP in Vancouver. Mr. Cherry has also served at the director and officer levels for a number of public mining companies. Mr. Cherry is the founder of Cherry Consulting, Ltd.

Robin Linden – Independent Director

Robin Linden contributes over 20 years of leadership and management experience, including roles at the University of Manitoba, Molson Breweries Canada, Canadian luxury retailer – Holt Renfrew, and Fairmont Hotels and Resorts.

Mr. Linden currently sits on the board of directors for MYM Nutraceuticals, a publicly traded Canadian medical cannabis company. He has been instrumental in initiating various projects, including the current construction of over 2.7 million square feet of cannabis production space in Canada and Australia. Mr. Linden brings with him experience in the branding and sales of a variety of cannabis-based products.

1) The global legal marijuana market is expected to reach $146.4 billion by the end of 2025and investors are already cashing in on a number of opportunities in the cannabis space. Orion Nutraceuticals (CSE: ORI) represents the next world-class cannabis play thanks to its unique advantages.

2) Orion offers investors an opportunity to profit from the rapidly-growing CBD market. This is a market projected to reach annual revenues of $2.1 billion by 2020 – an increase of more than 700% in just four years.

3) The company’s strategic JV partnership with FCM Global brings the many advantages of production in Colombia — the world’s best environment for scalable cannabis growth. This partnership could bring in as much as translate into $1.3 billion in gross sales potential for Orion Nutraceuticals (CSE: ORI) thanks to its 35% ownership stake.

4) Orion’s Quebec-based production headquarters – expected to be licensed by Health Canada in early 2019 – will include 30,000 square feet of growth capacity and will enable import/export of oil from Colombia (via FCM) to other parts of Canada, Europe, and wider international markets.

5) Orion’s senior management team is among the most impressive you’ll find in the cannabis space – including decades of experience and deep relationships within the industry – and is executing its vision to become a global leader in the production of medical and recreational cannabinoid extracts and oils, nutraceuticals and pharmaceuticals.

[i] https://www.grandviewresearch.com/press-release/global-legal-marijuana-market
[ii] https://www.forbes.com/sites/thomaspellechia/2018/03/01/double-digit-billions-puts-north-america-in-the-worldwide-cannabis-market-lead/#450fd35b6510
[iii] https://www.inc.com/will-yakowicz/cannabis-infused-beverages-could-be-the-new-soda.html
[iv] https://www.forbes.com/sites/debraborchardt/2016/12/12/the-cannabis-market-that-could-grow-700-by-2020/#3ce40bdb4be1

Disclaimer: This release/advertorial is a commercial advertisement prepared by DF Media (owner and publisher of Marijuanastox.com) and Winning Media LLC. (media placement company) and is for general information purposes only. This is a Native Advertisement, meaning it is an informational paid marketing piece. Winning Media and DF Media with the website MarijuanaStox.com make no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website. Please review all investment decisions with a licensed investment advisor. This Advertorial was paid for by Orion Nutraceuticals Inc. in an effort to enhance public awareness of Orion Nutraceuticals Inc. and its securities. Winning Media has received a cash budget by Orion Nutraceuticals Inc.for the sum total of one hundred twenty five thousand dollars cash as a total production budget for this advertising effort. Neither Marijuanastox.com or Winning Media currently holds the securities of Orion Nutraceuticals Inc. and does not currently intend to purchase such securities. This Advertorial contains forward-looking statements that involve risks and uncertainties. This Advertorial contains or incorporates by reference forward-looking statements, including certain information with respect to plans and strategies of the featured Company. As such, any statements contained herein or incorporated herein by reference that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, the words believe(s) anticipate(s), plan(s), expect(s) ,project(s) will make told and similar expressions are intended to identify forward-looking statements. There are a number of important factors that could cause actual events or actual results of the Company to differ materially from these indicated by such forward-looking statements. Certain statements contained herein constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934 and Canadian securities law. Further, this document includes statements regarding business, financing, business trends, future operating revenues and expenses and there can be no assurance that such expectations will prove to be correct. Investors are cautioned that any forward-looking statements made by the Company, or contained in this advertorial are not guarantees of future performance, and that the Issuers actual results may differ materially from those set forth in the forward-looking statements. Difference in results can be caused by various factors including, but not limited to, the Companys ability to be able to successfully complete planned funding agreements, to successfully market its products in competitive industries or to effectively implement its business plan or strategies. To reiterate, information presented in this advertorial contains forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact and may be forward-looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements in this advertorial may be identified through the use of words such as expects, will, anticipates, estimates, believes, may, or by statements indicating certain actions may, could, or might occur. More information on the Company may be found at www.sec.gov readers can review all public filings by the Company at Orions’s website and on SEDAR. Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this advertorial. Furthermore, the CSE has not reviewed, approved or disapproved the contents of this advertorial. Winning Media and MarijuanaStox.com are not certified financial analysts or licensed in the securities industry in any manner. The information in this Advertorial is subjective opinion and may not be complete, accurate or current and was paid for, so this could create a conflict of interest.


Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Indiana May Be On Its Way To A Medical Marijuana Program
18 August 2017
Marijuana Industry Ready To Confront The Trump Administration, Sources Say
18 April 2017
Orlando Attorney Wants Recreational Marijuana on Florida Ballot
27 June 2018